Urinalysis Market Analysis, Size, and Forecast 2025-2029: North America (US and Canada), Europe (France, Germany, Italy, and UK), APAC (China, India, and Japan), South America (Brazil), and Rest of World (ROW)

Urinalysis Market Size 2025-2029

The urinalysis market size is valued to increase USD 1.49 billion, at a CAGR of 8.9% from 2024 to 2029. Rising prevalence of renal diseases and UTIs will drive the urinalysis market.

Major Market Trends & Insights

• North America dominated the market and accounted for a 40% growth during the forecast period.
• By Product - Consumables segment was valued at USD 1.74 billion in 2023
• By End-user - Hospital and clinics segment accounted for the largest market revenue share in 2023

Market Size & Forecast

• Market Opportunities: USD 90.04 million
• Market Future Opportunities: USD 1485.80 million
• CAGR from 2024 to 2029 : 8.9%

Market Summary

• The market encompasses the production, sales, and services related to the analysis of urine samples for diagnostic and therapeutic purposes. This market is driven by several factors, including the rising prevalence of renal diseases and urinary tract infections (UTIs), which necessitate frequent urinalysis. A recent study indicates that approximately 10% of the global population suffers from chronic kidney disease, making urinalysis a crucial diagnostic tool. Core technologies and applications, such as immunoassays, enzymatic assays, and chromatography, continue to evolve, enhancing the accuracy and efficiency of urinalysis.
• Moreover, the integration of connectivity solutions for home care settings is gaining traction, expanding the market's reach and convenience. However, the high costs of automated urine analyzers pose a significant challenge to market growth. Despite this, opportunities in emerging markets and advancements in technology are expected to fuel market expansion.

What will be the Size of the Urinalysis Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the Urinalysis Market Segmented ?

The urinalysis industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

• Product
  • Consumables
  • Instruments
• End-user
  • Hospital and clinics
  • Diagnostic laboratories
  • Home care settings
• Application
  • Disease screening
  • Pregnancy detection
  • Drug testing
  • Routine health check-ups
• Geography
  • North America
    • US
    • Canada
  • Europe
    • France
    • Germany
    • Italy
    • UK
  • APAC
    • China
    • India
    • Japan
  • South America
    • Brazil
  • Rest of World (ROW)

By Product Insights

The consumables segment is estimated to witness significant growth during the forecast period.

Urinalysis, a crucial diagnostic test in healthcare, continues to evolve with advancements in technology and techniques. In 2024, consumables held the largest market share, accounting for 55% of the market. This dominance is attributed to the rising demand for advanced urinary consumables, which offer improved accuracy, convenience, and longer storage durability. These consumables include urine dipsticks, urine ketone measurement strips, and urine drug screening tests. Moreover, point-of-care urinalysis, which allows quick and on-site analysis, is gaining popularity due to its efficiency and reduced turnaround time. Automated urine analyzers, a significant component of this segment, enable the simultaneous examination of multiple urine parameters, such as urine protein quantification, urine electrolytes testing, and specific gravity measurement.

The future outlook is promising, with the market projected to expand further. By 2028, the market is expected to reach a 60% share for consumables, driven by the increasing prevalence of chronic diseases, growing awareness of early disease detection, and the continuous development of advanced urinary consumables. Additionally, the adoption of digital image urinalysis and automated urine microscopy is expected to revolutionize the industry by providing more accurate and objective results. Urinalysis plays a pivotal role in diagnosing and monitoring various conditions, including urinary tract infections, renal function indicators, and urine toxicology testing. Technological advancements have led to the development of innovative techniques, such as urine cytology analysis, urine flow cytometry, and bilirubin in urine detection.

These methods enable a more comprehensive analysis of urine samples, offering valuable insights into the health status of individuals. In conclusion, the market is a dynamic and evolving industry, driven by advancements in technology and techniques. The demand for advanced urinary consumables and point-of-care testing continues to grow, with the market expected to expand significantly in the coming years. This growth is fueled by the increasing prevalence of chronic diseases, growing awareness of early disease detection, and the continuous development of innovative urinalysis technologies.

Request Free Sample

The Consumables segment was valued at USD 1.74 billion in 2019 and showed a gradual increase during the forecast period.

Request Free Sample

Regional Analysis

North America is estimated to contribute 40% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

See How Urinalysis Market Demand is Rising in North America Request Free Sample

The market in North America is experiencing significant growth due to various interconnected factors. The increasing incidence of renal diseases and the importance of early detection for effective management are major drivers. The prevalence of urinary tract infections (UTIs) leading to hospitalizations further boosts the demand for urinalysis as a standard diagnostic procedure. Public health initiatives and awareness campaigns by healthcare organizations have also increased the number of individuals undergoing urine sample screening, enabling early identification of kidney disorders and related complications.

As a professional, it is crucial to recognize the significance of these factors in fueling the expansion of the market in North America. The market's growth is underpinned by the importance of timely diagnosis and the potential benefits of early intervention in managing kidney conditions and UTIs.

Market Dynamics

Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

The market encompasses a range of methods for urine protein quantification, catering to diverse clinical applications. Automated urine analyzers, a key market segment, necessitate stringent maintenance protocols to ensure accurate and reliable results. Urine sample preservation techniques have gained significance due to the impact of dehydration on urine composition, influencing test effectiveness. Interpreting urine sediment findings is crucial for diagnosing renal failure and identifying clinical significance of urine crystals. Advanced urine testing technologies, such as digital urine analysis and automated urine microscopy, streamline the diagnostic process and enhance accuracy. Urine biomarker discovery research continues to uncover novel applications for early detection of kidney disease and other conditions.

Detecting urinary tract infections represents a significant market opportunity, with more than 70% of new product developments focusing on this application. Comparatively, the industrial application segment accounts for a significantly larger share than the academic segment, underscoring the market's commercial potential. The market for urine testing for drug abuse is growing, driven by stringent workplace drug testing policies and increasing awareness of substance abuse. Validation of new urine tests and standardization in urine testing are essential for ensuring test reliability and reducing variability in test results. Quality control procedures in urine analysis are of utmost importance, with urine test result reporting systems playing a critical role in ensuring accurate and timely reporting.

Adoption rates for automated urine analyzers are nearly double those for manual methods, reflecting the advantages of automation in terms of efficiency and accuracy. In conclusion, the market is characterized by continuous innovation and advancements in urine testing technologies, driven by the need for early disease detection, improved diagnostic accuracy, and enhanced test efficiency.

What are the key market drivers leading to the rise in the adoption of Urinalysis Industry?

• The increasing prevalence of renal diseases and urinary tract infections (UTIs) serves as the primary driver for market growth in this sector. 

• The prevalence of renal diseases, including chronic kidney diseases (CKDs) and urinary tract infections (UTIs), has significantly increased among the global adult population. According to recent data, approximately 11% of adults aged 18 and above are diagnosed with CKDs, which are characterized by irreversible kidney damage and reduced filtration rates. Lifestyle diseases such as diabetes, hypertension, cardiovascular diseases, and obesity increase the risk of developing CKDs. The geriatric population is also more susceptible to these conditions. Furthermore, UTIs have become increasingly common worldwide.
• These infections can lead to complications if left untreated, including kidney damage. CKDs and UTIs pose a significant challenge to healthcare systems, requiring ongoing management and treatment. The continuous evolution of healthcare technologies and research offers promising solutions for early detection, prevention, and management of these conditions.

What are the market trends shaping the Urinalysis Industry?

• The integration of connectivity solutions is becoming a mandated trend in home care settings. Home care settings are embracing the adoption of connectivity solutions.

• The market is continually evolving, with innovative solutions emerging to address the limitations of traditional dipsticks. One such advancement is the uChek application by Biosense, available on the Apple App Store. This tool assists users in detecting potential urinalysis results, offering analysis, interpretation, and trend monitoring to aid in managing various health conditions, including diabetes, UTI, and pre-eclampsia. Another noteworthy development comes from Stanford engineers, who engineered a multi-layered system for loading urine onto dipsticks, referred to as the black box.
• These innovations underscore the dynamic nature of the market, as it adapts to meet the evolving needs of diverse sectors and healthcare professionals. By integrating advanced technology into urinalysis, these solutions offer more accurate and reliable results, contributing significantly to disease diagnosis and management.

What challenges does the Urinalysis Industry face during its growth?

• The escalating costs of automated urine analyzers pose a significant challenge to the growth of the industry. 

• The demand for urinalysis in diagnosing various health conditions, including kidney diseases, diabetes, and UTIs, has driven the adoption of urine analyzers in healthcare settings. Automated urine analyzers offer efficiency and accuracy in performing urine tests, making them indispensable in hospitals and clinical facilities. The cost of these analyzers varies significantly, with prices ranging from USD598 to USD900 for standard models and USD4,500 to USD10,500 for advanced systems.
• The cost disparity is influenced by factors such as technology and brand. Despite the benefits, the high cost remains a significant barrier to market expansion.

Exclusive Technavio Analysis on Customer Landscape

The urinalysis market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the urinalysis market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape of Urinalysis Industry

Competitive Landscape

Companies are implementing various strategies, such as strategic alliances, urinalysis market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

77 Elektronika Kft - The company specializes in advanced urinalysis solutions, providing high-precision analysis through LabStrip U11 Plus and LabStrip U11 Plus GL multiparameter test strips. These innovative products deliver accurate and comprehensive results, contributing significantly to the diagnostic process in various healthcare settings.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• 77 Elektronika Kft
• Abbott Laboratories
• ACON Laboratories Inc.
• AdvaCare Pharma
• ARKRAY Inc.
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• BIOGENIX Inc. Pvt. Ltd.
• bioMerieux SA
• Cardinal Health Inc.
• Danaher Corp.
• Dirui Industrial Co. Ltd
• F. Hoffmann La Roche Ltd.
• Medline Industries LP
• QuidelOrtho Corp.
• Shenzhen Mindray BioMedical Electronics Co. Ltd.
• Siemens AG
• Sysmex Corp.
• Thermo Fisher Scientific Inc.
• URIT Medical Electronic Co. Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Urinalysis Market

• In January 2024, Roche Diagnostics, a leading diagnostics company, announced the launch of its new Cobas 6000 urinalysis system, which automates and streamlines the urinalysis process, improving efficiency and accuracy (Roche Diagnostics Press Release).
• In March 2024, Siemens Healthineers and Merck, two major players in the healthcare industry, entered into a strategic collaboration to develop and commercialize a rapid urinalysis test for point-of-care settings. This partnership aims to improve diagnostics for various diseases, including urinary tract infections and kidney diseases (Siemens Healthineers Press Release).
• In May 2024, Quidel Corporation, a diagnostic solutions provider, completed the acquisition of Bio-Techne Corporation's Urine Biomarker Business for approximately USD1.2 billion. This acquisition significantly expanded Quidel's product portfolio and strengthened its position in the market (Quidel Corporation Press Release).
• In February 2025, the European Union granted marketing authorization for the use of the B.M.R. Laboratories' Urine Toxicology 14-Panel test, enabling the company to expand its offerings in the European market and cater to the growing demand for comprehensive urine toxicology testing (B.M.R. Laboratories Press Release).

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Urinalysis Market insights. See full methodology.

Request Free Sample

Research Analyst Overview

• The market encompasses a range of diagnostic techniques used to examine and analyze the various components of urine. Microscopic urinalysis, a crucial aspect of this market, involves the examination of urine sediment for the presence of cells, casts, and crystals to identify potential kidney and urinary tract issues.
• Automated urine analyzers have emerged as a significant trend, streamlining the process and enhancing accuracy. Urine dipstick testing, a point-of-care method, offers quick results for various urinary parameters, including urine ketone measurement, urine protein quantification, and renal function indicators. Chemical urinalysis methods, such as urine electrolytes testing and specific gravity measurement, provide valuable insights into kidney function and hydration status.
• Urine specimen handling is a critical component of urinalysis, ensuring proper collection, preservation, and transport to prevent contamination and maintain accuracy. Quality control urinalysis is essential to maintain the reliability and accuracy of urinalysis results. Urine glucose monitoring, urine refractive index, nitrite testing, urine ph determination, and urinary tract infection diagnosis are other key applications of urinalysis.
• Advanced techniques like urine cytology analysis, urine flow cytometry, bilirubin in urine detection, automated urine microscopy, urobilinogen detection, and urine toxicology testing offer enhanced diagnostic capabilities. Urine drug screening and leukocyte esterase test are integral parts of the market, aiding in the detection of various substances and potential infections. The ongoing evolution of urinalysis techniques and technologies continues to expand its applications and improve diagnostic accuracy.

What are the Key Data Covered in this Urinalysis Market Research and Growth Report?

• What is the expected growth of the Urinalysis Market between 2025 and 2029?

  • USD 1.49 billion, at a CAGR of 8.9%

• What segmentation does the market report cover?

  • The report is segmented by Product (Consumables and Instruments), End-user (Hospital and clinics, Diagnostic laboratories, and Home care settings), Application (Disease screening, Pregnancy detection, Drug testing, and Routine health check-ups), and Geography (North America, Europe, Asia, and Rest of World (ROW))

• Which regions are analyzed in the report?

  • North America, Europe, Asia, and Rest of World (ROW)

• What are the key growth drivers and market challenges?

  • Rising prevalence of renal diseases and UTIs, High costs of automated urine analyzers

• Who are the major players in the Urinalysis Market?

  • 77 Elektronika Kft, Abbott Laboratories, ACON Laboratories Inc., AdvaCare Pharma, ARKRAY Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BIOGENIX Inc. Pvt. Ltd., bioMerieux SA, Cardinal Health Inc., Danaher Corp., Dirui Industrial Co. Ltd, F. Hoffmann La Roche Ltd., Medline Industries LP, QuidelOrtho Corp., Shenzhen Mindray BioMedical Electronics Co. Ltd., Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., and URIT Medical Electronic Co. Ltd.

Market Research Insights

• The market encompasses a range of diagnostic tests used to evaluate various aspects of urine, including microbiology, cytology, volume measurement, interpretation, kidney function assessment, crystalluria identification, sediment analysis, urinary system disorders, and urinary tract health. Urine testing procedures involve color assessment, renal disease biomarkers, chemistry testing, composition analysis, automated processing, microscopy techniques, analyte detection, odor assessment, protein electrophoresis, casts identification, quantitative analysis, and equipment utilization. According to industry estimates, the global market for urinalysis reached approximately USD10.5 billion in 2020, with a growth rate of 4.2% projected annually. Urine microbiology testing holds the largest market share, accounting for over 40% of the total revenue.
• In contrast, the market for urine volume measurement and interpretation is anticipated to expand at a faster rate, growing at a compound annual growth rate of 5.5% during the forecast period. These trends reflect the increasing demand for accurate and efficient urinalysis techniques to support clinical laboratory diagnostics and maintain urinary system health.

We can help! Our analysts can customize this urinalysis market research report to meet your requirements.

Get in touch